SCHEMBL17040910

SCHEMBL17040910

CNc1ccc(CNC(=O)OC(C)(C)C)cc1S

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 2/20 0.44
▸ HDAC1 Q13547 2/20 0.44
▸ NAMPT P43490 2/20 0.43
▸ GAA P10253 1/20 0.42
▸ KDM4A O75164 1/20 0.42
▸ TSHR P16473 1/20 0.41
▸ GRM2 Q14416 1/20 0.41
▸ GLS O94925 2/20 0.41
▸ CA1 P00915 1/20 0.40
▸ CA2 P00918 1/20 0.40
▸ BRD9 Q9H8M2 1/20 0.39
▸ BAZ2B Q9UIF8 1/20 0.39
▸ BAZ2A Q9UIF9 1/20 0.39
▸ BRD4 O60885 1/20 0.39
▸ MAPT P10636 2/20 0.38
▸ TDP1 Q9NUW8 1/20 0.38
▸ HDAC10 Q969S8 1/20 0.38
▸ HDAC6 Q9UBN7 1/20 0.38
▸ RECQL P46063 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8649137 0.80 MTNR1A (0.42) L3MBTL1HDAC1NAMPTGAAKDM4A
SCHEMBL3180689 0.79 L3MBTL1 (0.61) L3MBTL1HDAC1NAMPTGAAKDM4A
SCHEMBL732456 0.77 NAMPT (0.57) L3MBTL1HDAC1NAMPTGAAKDM4A
SCHEMBL12685839 0.76 L3MBTL1 (0.56) L3MBTL1HDAC1NAMPTGAAKDM4A
SCHEMBL23386279 0.76 CA12 (0.46) HDAC1NAMPTGAACA1HDAC6
SCHEMBL25738303 0.76 CA12 (0.56) GAACA1CA2BRD4TDP1
SCHEMBL13055397 0.76 KDM4A (0.51) L3MBTL1HDAC1NAMPTGAAKDM4A
SCHEMBL5749285 0.76 ERCC1 (0.56) L3MBTL1HDAC1NAMPTGAACA1
SCHEMBL31709823 0.75 BRD4 (0.54) L3MBTL1HDAC1NAMPTKDM4AGLS
SCHEMBL731764 0.75 BRD4 (0.54) L3MBTL1HDAC1NAMPTKDM4AGLS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150239878-A1 Novel Compounds for Imaging Tau Proteins That Accumulate In Brain NATIONAL INSTITUTES FOR QUANTUM AND RADIOLOGICAL SCIENCE AND TECHNOLOGY (JP) 2015-08-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150239878-A1 Novel Compounds for Imaging Tau Proteins That Accumulate In Brain MAPT, FABP7, HTT L3MBTL1 2624/4885HDAC1 1398/4885NAMPT 4851/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback